BDBM632955 US20230348453, Compound C3

SMILES Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)nccc2Br)cc(n1)N1CCN(CCO)CC1

InChI Key InChIKey=KSCBSHLEWGZVON-UHFFFAOYSA-N

Data  5 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 19 hits for monomerid = 632955   

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 1.59nMAssay Description:The IC50 for the inhibition of ABL1 by dasatinib, by C7 and by B3 is approximately 1.5 nM, 5.1 nM and 1.6 nM, and of SRC is 1.5 nM, 1.5 nM and 1.5 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 1.59nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 39.7nMAssay Description:The IC50 for the inhibition of ABL1 by dasatinib, by C7 and by B3 is approximately 1.5 nM, 5.1 nM and 1.6 nM, and of SRC is 1.5 nM, 1.5 nM and 1.5 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 39.7nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase SIK1(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 571nMAssay Description:The IC50 for the inhibition of ABL1 by dasatinib, by C7 and by B3 is approximately 1.5 nM, 5.1 nM and 1.6 nM, and of SRC is 1.5 nM, 1.5 nM and 1.5 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSerine/threonine-protein kinase SIK1(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 571nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase SIK2(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 1.54E+3nMAssay Description:The IC50 for the inhibition of ABL1 by dasatinib, by C7 and by B3 is approximately 1.5 nM, 5.1 nM and 1.6 nM, and of SRC is 1.5 nM, 1.5 nM and 1.5 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSerine/threonine-protein kinase SIK2(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 1.54E+3nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase SIK2(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 2.78E+3nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase SIK2(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 2.78E+3nMAssay Description:The IC50 for the inhibition of ABL1 by dasatinib, by C7 and by B3 is approximately 1.5 nM, 5.1 nM and 1.6 nM, and of SRC is 1.5 nM, 1.5 nM and 1.5 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1 (Y253F)(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 1.61E+4nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 1.83E+4nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1 (Q252H)(Homo sapiens (Human))
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 2.97E+4nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1 (H396P)(Homo sapiens (Human))
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 3.25E+4nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1 [M351T](Homo sapiens (Human))
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 3.70E+4nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1 [G250E](Homo sapiens (Human))
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 1.01E+5nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1 [E255K](Homo sapiens (Human))
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 1.11E+5nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1 [F317I](Homo sapiens (Human))
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 8.23E+5nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1 [T315I](Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632955(US20230348453, Compound C3 | US12172993, Compound ...)
Affinity DataIC50: 4.38E+7nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent